Small Molecule API Market
- 2026 年市場規模
- USD 130.4 Bn
- 2033 年預估規模
- USD 177.4 Bn
- 年複合成長率 CAGR
- 4.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Small Molecule API Market , By API Type (Synthetic and Biological), By Application (Oncology, Neurology, Metabolic, Infectious, and Cardiovascular), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
報告摘要
A small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic compound, which may help to control biological process. Most of the small molecules can be administered orally and are most likely to be absorbed by the body. Owing to its small size it has properties of rapid diffusibility to reach the intracellular site of action.
Market Dynamics
Growing expansion of small molecule API manufacturers in the Asia Pacific region is a major factor driving the small molecule API market growth. For instance, BASF is planning to build a new specialty amines plant at its existing site in Nanjing Chemical Industry Park, China. This new multi-product plant will be able to manufacture 21,000 metric tons of amines year, and it extends BASF’s amines portfolio at the specialty amines complex in Nanjing. The plant is scheduled to stream by 2019. Moreover the small molecule API manufacturers have planned to add global sales and business development staff, followed by quality, regulatory, and project management teams, which have positively influenced growth of the market.
However, stringent regulatory policies for API manufacturing may hinder the market growth. Stringent global regulatory policies on quality assessments of small molecule API manufacturing, facility certification, and increased supply chain security issues across emerging countries have a large impact on the cost of final small molecule API products. The new entrants willing to enter into small molecule API manufacturing are facing financial challenges, owing to aforementioned factors.
Key features of the study
• This report provides in-depth analysis of the small molecule API market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 – 2033), considering 2025 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, impact analysis, PEST analysis, collaborations, mergers and acquisitions, regulatory scenarios, technological advancements, steps to manufacture small molecule API, major suppliers of small molecule APIs, market trends
• It profiles key players in the global small molecule API market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
• Key companies covered as a part of this study include, Lonza, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Aesica Pharmaceuticals Ltd., Albemarle Corporation, Cambrex Corporation, BASF SE, Gland Pharma Limited, Gilead Sciences, Inc., AstraZeneca Plc, Baxter International Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, Piramal Pharma Solutions, Recipharm AB, Evonik Industries AG, Glenmark Pharmaceuticals Limited, Siegfried AG, AbbVie Contract Manufacturing, Aurinia Pharmaceuticals Inc., Bayer AG, Patheon, CordenPharma International
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
• The global small molecule API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the small molecule API market
Market Segmentation
• API Type Insights (Revenue, USD Bn, 2026 - 2033)
o Synthetic
o Biological
• Application Insights (Revenue, USD Bn, 2026 - 2033)
o Oncology
o Neurology
o Metabolic
o Infectious
o Cardiovascular
• Regional Insights (Revenue, USD Bn, 2026 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players Insights
o ALLERGAN
o Aurobindo Pharma
o Cambrex Corporation
o Albemarle Corporation
o dr. Reddy’s Laboratories Ltd.
o Johnson Matthey
o Siegfried Holding AG
o Pfizer
o Sanofi S.A.
o Novartis AG
o Johnson & Johnson
o Bristol-Myers Squibb
o Bachem Holding AG
o Boehringer Ingelheim GmbH
o Hoffmann-La Roche Ltd
o GlaxoSmithKline PLC
o GILEAD Science Inc.
o Albany Molecular Research Inc.
o Sun Pharmaceuticals
o AstraZeneca
o Merck & Co, Inc.
o BASF SE
o Teva Pharmaceuticals
目錄 Table of Contents
Table of Contents
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By API Type
Market Snippet, By Application
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
PEST Analysis
PORTER’s Five Forces Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trend
4. Global Small Molecule API Market, By API Type, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Synthetic
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Biological
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
5. Global Small Molecule API Market, By Application, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 - 2033
Segment Trends
o Oncology
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Neurology
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Metabolic
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Infectious
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
o Cardiovascular
Market Share Analysis, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, 2021 – 2033
Segment Trends
6. Global Small Molecule API Market, By Region, 2026-2033, (USD Bn)
o Introduction
Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2033
o North America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o U.S.
o Canada
o Latin America
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o Brazil
o Argentina
o Mexico
o Rest of Latin America
o Europe
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of Asia Pacific
o Middle East
Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country, 2021 - 2033
Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o GCC Countries
o Israel
o Rest of Middle East
o Africa
Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
o South Africa
o North Africa
o Central Africa
7. Competitive Landscape
o Heat Map Analysis
o Market Share Analysis (3x3 Matrix)
o Company Profiles
ALLERGAN
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Aurobindo Pharma
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Cambrex Corporation
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Albemarle Corporation
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
D.r. Reddy’s Laboratories Ltd.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Johnson Matthey
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Siegfried Holding AG
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Pfizer
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Sanofi S.A.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Novartis AG
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Johnson & Johnson
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Bristol-Myers Squibb
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Bachem Holding AG
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Boehringer Ingelheim GmbH
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
F. Hoffmann-La Roche Ltd
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
GlaxoSmithKline PLC
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
GILEAD Science Inc.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Albany Molecular Research Inc.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Sun Pharmaceuticals
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
AstraZeneca
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Merck & Co, Inc.
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
BASF SE
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
Teva Pharmaceuticals
o Company Overview
o Product Type Portfolio
o Recent Developments/Updates
8. Analyst Recommendation
o Wheel of Fortune
o Analyst View
o Coherent Opportunity Map
9. Section
o References
o Research Methodology
o About Us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們